Status:
COMPLETED
Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents
Lead Sponsor:
Women and Infants Hospital of Rhode Island
Collaborating Sponsors:
University of Rhode Island
Conditions:
Sexually Transmitted Diseases
Substance-Related Disorders
Eligibility:
All Genders
15-18 years
Phase:
NA
Brief Summary
The purpose of this study is to develop and pilot test a partner-specific HIV risk reduction intervention for currently or recently incarcerated adolescents who report problematic substance use.
Detailed Description
Incarcerated adolescents represent a group at high risk for health consequences associated with risky sexual behaviors. Condom use is more common with non-main than main sex partners and substance use...
Eligibility Criteria
Inclusion
- English-speaking ability
- unprotected vaginal, anal, or oral intercourse at least once in the 6 months prior to incarceration or placement
- marijuana use disorders, other non-injection drug use disorders, or substance use by a sexual partner during a sexual episode in the six months prior to incarceration or placement
- sentence or placement length between 2 and 12 months
- must plan to remain in the area for the 6 months following their release from the facility
- must be willing to provide two pieces of contact information for follow-up
Exclusion
- signs of psychosis (assessed through clinical assessment)
Key Trial Info
Start Date :
February 1 2009
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2011
Estimated Enrollment :
59 Patients enrolled
Trial Details
Trial ID
NCT00831883
Start Date
February 1 2009
End Date
January 1 2011
Last Update
December 5 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Women & Infants Hospital of Rhode Island
Providence, Rhode Island, United States, 02905